MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,647 | -12.4% | 73,276 | -9.9% | 0.02% | -32.4% |
Q1 2023 | $3,022 | -98.9% | 81,306 | +2022.9% | 0.04% | +1133.3% |
Q3 2022 | $267,000 | -94.2% | 3,830 | -87.8% | 0.00% | -88.9% |
Q4 2021 | $4,603,000 | -75.9% | 31,382 | -73.4% | 0.03% | -84.6% |
Q2 2021 | $19,081,000 | +193.8% | 118,131 | +299.5% | 0.18% | +33.6% |
Q4 2020 | $6,494,000 | +634.6% | 29,567 | +156.9% | 0.13% | +129.8% |
Q1 2020 | $884,000 | -58.5% | 11,508 | -57.9% | 0.06% | -43.0% |
Q3 2019 | $2,129,000 | – | 27,338 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |